AI-designed drug Rentosertib unexpectedly lowered patients' biological age markers by 6 years
Distinct-Question-16 · reddit · 2026-09-08
Rentosertib, an experimental drug designed by Insilico Medicine using AI for an incurable lung disease, showed a surprising trial effect: patients' biological age indicators shifted toward a younger state by about six years. The anti-aging signal is unexpected and awaits further validation.
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Research
- Lab monkeys at $30-80K each: a 4-year breeding cycle is the real preclinical drug bottleneck — zebird0 · 2026-10-27
- OpenAI Foundation funds UNC tumor antigen project, hiring senior experimental scientist — iskander · 2026-10-27
- Steering attention heads toward honesty: up moral patienthood, down psychopathy — edelwax · 2026-10-27
- Are transcoders overkill? New paper argues plain neurons suffice for circuit analysis — burny_tech · 2026-10-27
- EMNLP paper GENIE: a fine-grained metric locating where LLM stories are novel — gregd_nlp · 2026-10-27
- Hashed n-gram value embeddings push GPT to 3.2115 loss, beating 30M track record — RobertTLange · 2026-10-27